focus -WSS

focus

author：explore 2025-09-29 20:53:03 - browse：17

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use.

The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.’s second most expensive drug, behind a recently approved gene therapy for hemophilia. CEO Doug Ingram said on a conference call the price was below what a recently published company-funded analysis found would be cost-effective.

“The approval of Elevidys is a watershed moment for the treatment of Duchenne. Elevydis is the first and only gene therapy approved for Duchenne, and this approval brings us closer to our goal of bringing forward a treatment that provides the potential to alter the trajectory of this degenerative disease,” Ingram said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： A rare thyroid diagnosis led to unexpected, all

WSS

Walensky prepares to leave CDC — and Congress — behind

Trump surgeon general acknowledges mistakes during Covid

Novavax promises a turnaround & Lilly roils the obesity market

Humana sues Biden admin over Medicare Advantage audit rule

Guidelines to prevent youth baseball injuries need more muscle

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

focus

focus

hotspot

Medical records are filled with copy

Anesthesiologist group: stop taking Ozempic before surgery

Virginia high school admissions case could be legal follow

Drug repurposing or repositioning? The language matters

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

State Dept. review finds Biden bears some blame for Afghanistan failures

At least 13 dead in Texas as scorching temps continue

How to fix cancer clinical trials' diversity problem

Guidelines to prevent youth baseball injuries need more muscle

23andMe had bad news about my health. I wish a person had delivered it

explore

A rare thyroid diagnosis led to unexpected, all

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

The 10 drugs up first for Medicare price negotiation

George Santos makes 1st court appearance after pleading not guilty to 13 counts

AstraZeneca chief proposes a novel edit to the drug pricing bill

knowledge

entertainment

leisure time

knowledge